← Back to Analyst Consensus 
JANX Buy
Janux Therapeutics, Inc.
Current Price —
Implied Upside —
Analysts 25
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 10, 2026 (15 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Aug 24, 2026 | Wolfe Research | upgrade | Peer Perform → Outperform | — | 54% |
| Aug 7, 2026 | Guggenheim | maintain | Buy → Buy | — | 52% |
| May 8, 2026 | Piper Sandler | maintain | Overweight → Overweight | — | 54% |
| May 8, 2026 | Wedbush | maintain | Outperform → Outperform | — | 58% |
| May 8, 2026 | Guggenheim | maintain | Buy → Buy | — | 52% |
| Apr 28, 2026 | Jones Trading | maintain | Buy → Buy | — | 50% |
| Apr 20, 2026 | Barclays | downgrade | Overweight → Underweight | — | 53% |
| Apr 15, 2026 | UBS | downgrade | Buy → Neutral | — | 54% |
| Feb 27, 2026 | Cantor Fitzgerald | maintain | Overweight → Overweight | $100 | 50% |
| Feb 27, 2026 | Guggenheim | maintain | Buy → Buy | $68 | 52% |
| Jan 20, 2026 | Clear Street | downgrade | Buy → Hold | $12 | 48% |
| Jan 16, 2026 | Piper Sandler | maintain | Overweight → Overweight | $30 | 54% |
| Dec 17, 2025 | Barclays | maintain | Overweight → Overweight | $29 | 53% |
| Dec 2, 2025 | Stifel | maintain | Buy → Buy | $38 | 53% |
| Dec 2, 2025 | Clear Street | maintain | Buy → Buy | $32 | 48% |
| Dec 2, 2025 | B of A Securities | maintain | Buy → Buy | $49 | 53% |
| Dec 2, 2025 | Cantor Fitzgerald | maintain | Overweight → Overweight | $150 | 50% |
| Dec 2, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $45 | 44% |
| Nov 25, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $70 | 44% |
| Nov 18, 2025 | Wolfe Research | initiate | — → Peer Perform | $0 | 54% |
| Nov 7, 2025 | Barclays | maintain | Overweight → Overweight | $48 | 53% |
| Sep 17, 2025 | Barclays | initiate | — → Overweight | $47 | 53% |
| Sep 10, 2025 | Truist Securities | initiate | — → Buy | $100 | 54% |
| Sep 4, 2025 | Guggenheim | initiate | — → Buy | $72 | 52% |
| Aug 19, 2025 | Piper Sandler | initiate | — → Overweight | $42 | 54% |
| Jul 11, 2025 | Raymond James | initiate | — → Outperform | $65 | 54% |
| Mar 3, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $70 | 44% |
| Feb 28, 2025 | Scotiabank | maintain | Sector Perform → Sector Perform | $41 | 55% |
| Dec 11, 2024 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $200 | 50% |
| Dec 4, 2024 | Scotiabank | maintain | Sector Perform → Sector Perform | $62 | 55% |
| Dec 3, 2024 | Stifel | maintain | Buy → Buy | $115 | 53% |
| Dec 3, 2024 | Leerink Partners | maintain | Outperform → Outperform | $91 | 50% |
| Dec 3, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $70 | 44% |
| Nov 22, 2024 | Leerink Partners | initiate | — → Outperform | $79 | 50% |
| Nov 7, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $63 | 44% |
| Nov 7, 2024 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $100 | 50% |
| Oct 24, 2024 | UBS | initiate | — → Buy | $69 | 54% |
| Sep 16, 2024 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $100 | 50% |
| Sep 6, 2024 | Stifel | initiate | — → Buy | $70 | 53% |
| Aug 19, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $63 | 44% |
| Aug 9, 2024 | Scotiabank | maintain | Sector Perform → Sector Perform | $42 | 55% |
| Aug 8, 2024 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $100 | 50% |
| Aug 8, 2024 | Wedbush | reiterate | Outperform → Outperform | $74 | 58% |
| May 30, 2024 | Scotiabank | initiate | — → Sector Perform | $47 | 55% |
| May 13, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $63 | 44% |
| May 9, 2024 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $100 | 50% |
| May 8, 2024 | Wedbush | maintain | Outperform → Outperform | $74 | 58% |
| Apr 16, 2024 | JonesTrading | initiate | — → Buy | $70 | 75% |
| Mar 21, 2024 | BTIG | initiate | — → Buy | $62 | 52% |
| Mar 20, 2024 | Cantor Fitzgerald | initiate | — → Overweight | $100 | 50% |
Price Target Trend
Jun 17, 2026 Latest: $36.24 Oct 22, 2026
EPS Estimates
0y $-1.73
Lo: $-2.29 Hi: $-0.97
14 analysts +1y $-2.62
Lo: $-3.17 Hi: $-2.06
13 analysts ▲5
0q $-0.49
Lo: $-0.67 Hi: $-0.04
14 analysts +1q $-0.57
Lo: $-0.81 Hi: $-0.32
14 analysts Cross-Platform Signals
No cross-platform signals in the last 90 days